Skip to main content

Advertisement

ADVERTISEMENT

News

News
01/05/2022
Anthos Therapeutics announced the appointment of David McIntyre as Chief Financial Officer. Mr. McIntyre will assume responsibility for the company's finance and investor relation functions.
Anthos Therapeutics announced the appointment of David McIntyre as Chief Financial Officer. Mr. McIntyre will assume responsibility for the company's finance and investor relation functions.
Anthos Therapeutics announced...
01/05/2022
EP Lab Digest
News
01/05/2022
MediLynx Cardiac Monitoring, LLC has received a broad patent for continuous (full-disclosure) ECG streaming, analysis and monitoring from a remote location.
MediLynx Cardiac Monitoring, LLC has received a broad patent for continuous (full-disclosure) ECG streaming, analysis and monitoring from a remote location.
MediLynx Cardiac Monitoring, LLC...
01/05/2022
EP Lab Digest

Advertisement

News
01/04/2022
Great Debates & Updates in Electrophysiology (GDU EP), the official meeting of EP Lab Digest, has announced its dates for 2022! This unique, debate-style conference is also now complimentary for clinicians. Register today!
Great Debates & Updates in Electrophysiology (GDU EP), the official meeting of EP Lab Digest, has announced its dates for 2022! This unique, debate-style conference is also now complimentary for clinicians. Register today!
Great Debates & Updates in...
01/04/2022
EP Lab Digest
News
12/23/2021
Imagine visiting the doctor, answering a few basic questions and getting an on-the-spot estimate of whether you'll experience heart failure in the next 30 years. Such a model now exists, thanks to a new Northwestern Medicine study, which...
Imagine visiting the doctor, answering a few basic questions and getting an on-the-spot estimate of whether you'll experience heart failure in the next 30 years. Such a model now exists, thanks to a new Northwestern Medicine study, which...
Imagine visiting the doctor,...
12/23/2021
Cath Lab Digest
News
12/22/2021
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an...
Novartis today announced the US Food and Drug Administration (FDA) approval of Leqvio® (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (LDL-C) with two doses a year, after an...
Novartis today announced the US...
12/22/2021
Cath Lab Digest

Advertisement

News
12/22/2021
AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced that KardiaMobile 6L, the most clinically-validated six-lead personal ECG device, is now available via KardiaPro on Epic's App Orchard...
AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, announced that KardiaMobile 6L, the most clinically-validated six-lead personal ECG device, is now available via KardiaPro on Epic's App Orchard...
AliveCor, the global leader in...
12/22/2021
EP Lab Digest
News
12/21/2021
First enrollment comes as investors provide $75M toward an oversubscribed Series C financing.
First enrollment comes as investors provide $75M toward an oversubscribed Series C financing.
First enrollment comes as...
12/21/2021
EP Lab Digest
News
12/16/2021
Algorithm reduces the volume of false positives from Medtronic implantable loop recorders by nearly 80% to boost medical staff productivity by focusing on meaningful cardiac arrhythmia events.
Algorithm reduces the volume of false positives from Medtronic implantable loop recorders by nearly 80% to boost medical staff productivity by focusing on meaningful cardiac arrhythmia events.
Algorithm reduces the volume of...
12/16/2021
Cath Lab Digest

Advertisement

News
12/15/2021
AtaCor Medical, Inc. announced that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study.
AtaCor Medical, Inc. announced that it has completed enrollment in its initial acute Extravascular Implantable Cardioverter Defibrillator (EV-ICD) study.
AtaCor Medical, Inc. announced...
12/15/2021
EP Lab Digest
News
12/15/2021
December 15, 2021 — People who suffer from both insomnia and obstructive sleep apnea are more likely to suffer from heart problems and are almost 50% more likely to die than those without either condition, say Flinders University researchers,...
December 15, 2021 — People who suffer from both insomnia and obstructive sleep apnea are more likely to suffer from heart problems and are almost 50% more likely to die than those without either condition, say Flinders University researchers,...
December 15, 2021 — People who...
12/15/2021
Cath Lab Digest

Advertisement